Navigation Links
ERT Reports First Quarter 2009 Results
Date:4/30/2009

PHILADELPHIA, April 30 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERES), a leading provider of centralized ECG, eClinical technology, ePRO and other services to the biopharmaceutical, medical device, and related industries, announced today results for the first quarter of 2009. Unless otherwise noted, all comparative numbers refer to changes from the same period a year ago.

Highlights of the first quarter were:

  • Quarterly net revenue was $23.8 million for the first quarter of 2009 compared to $33.7 million a year ago.
  • Gross margin percentage was 50.4% in the first quarter of 2009 compared to 52.5% a year ago.
  • Operating income margin percentage was 14.0% in the first quarter of 2009 compared to 25.2% a year ago.
  • ERT's tax rate was 40.1% in the first quarter of 2009 compared to 35.6% a year ago.
  • Net income was $2.1 million for the first quarter of 2009 compared to $5.7 million a year ago.
  • Diluted net income per share was $0.04 in the first quarter of 2009 compared to $0.11 a year ago.
  • New bookings were $31.2 million in the first quarter of 2009 compared to $50.1 million a year ago.
  • Total expenses were $20.4 million in the first quarter of 2009, compared to $25.2 million a year ago.
  • Cash flow from operations in the first quarter of 2009 was $9.1 million, compared to $7.6 million a year ago.
  • Cash, cash equivalents and investments totaled $65.6 million at March 31, 2009 compared to $66.4 million at December 31, 2008.
  • ERT purchased 1,965,452 shares of its common stock at an average price of $5.05 under its approved stock repurchase program in the first quarter of 2009 at a total cost of $10.0 million.
  • Backlog w
    '/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. CryoLife Reports Record First Quarter Revenues of $26.7 Million
2. Caliper Life Sciences Reports First Quarter 2009 Results
3. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
4. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
5. Vanda Pharmaceuticals Reports First Quarter 2009 Results
6. Telik Reports Preclinical Results at AACR Annual Meeting
7. PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
8. Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial
9. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
10. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
11. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 BioPlus Specialty ... specialty pharmacies, has an expanded team of Regional ... consultants for prescriber offices in their regions, with ... “We have a variety of Regional Pharmaceutical Care ... specializing in hepatitis C help prescribers understand all ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... N.Y. , Dec. 18, 2014 Egenix, Inc. ... has been elected Chairman of the Board, to succeed ... and CEO, but will continue as a member of the ... he has added to the company over almost twenty years, ... The Board of Directors has established a Search Committee ...
(Date:12/17/2014)... (PRWEB) December 16, 2014 “Never ... at Philipps- Universität Marburg’s Department of Physics, advises ... in the newly released SPIE Women in ... be too shy to ask questions.” , In ... engineering, and mathematics) occupations ranging from university professor ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3
... LA JOLLA, Calif., Nov. 25 TorreyPines Therapeutics, Inc.,(Nasdaq: ... purchased from Eli Lilly & Company,a reduction in certain ... on,net sales of TorreyPines, clinical-stage compounds NGX426 and tezampanel,should ... tier,royalty rate will be reduced three percentage points and ...
... 25 t2cure, a,biopharmaceutical company developing regenerative medicine ... that it has acquired a family of,patents and ... Frankfurt University. , ... for the rapid characterization,of the potency of bone ...
... FRANCISCO, Calif., Nov. 25 Sunesis Pharmaceuticals, Inc. (Nasdaq: ... of new oncology therapeutics for the treatment of solid and hematologic ... following upcoming conferences during the month of December: , ... Annual Health Care Conference , The New ...
Cached Biology Technology:TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel 2t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application 2Sunesis to Present at Upcoming Conferences 2
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/5/2014)... Utah , Dec. 4, 2014  Tute Genomics, ... raised $2.3 million in Series A1 funding led by ... investors also participated in the investment round. ... the healthcare community adopts next-generation sequencing and seeks new ... said Reid Robison , MD MBA, and CEO ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2
... If world leaders do not immediately engage in a race ... ecosystems will not survive the global warming and acidification predicted ... group of marine scientists from around the world in a ... 13., "It,s vital that the public understands that the lack ...
... at Stevens Institute of Technology, won first place at ... in November 2007. Freed was the first competitor from ... poster, Impedance Mammography, was based on a project she ... April 2007, the New Jersey Regional ISPE Poster Contest ...
... 20, 2007) -- At its core, healthy neurological function hinges ... the synapse. Figuring out how the synapse traffics this ... understanding the function of the healthy and diseased brain. ... Medical College in New York City has spotted a crucial ...
Cached Biology News:Major study concludes that global warming is killing off coral 2Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 2A key enzyme helps keep the synapse on track 2A key enzyme helps keep the synapse on track 3
... Cassettes facilitate the hybridization of DNA or ... 25mm x 75mm glass slides. The proprietary ... correct for poor flatness, as is often ... low volume chamber (67uL analytical cavity volume) ...
... This reagent is formulated specifically for Alkaline ... high levels of activity for both the ... at final dilution. This product has ... providing the customer a longer shelf life, ...
... Lambda Free Light Chain ... of human immunoglobulin. Specificity: ... epitope of lambda chain. Reacts with ... lambda chains but not with lambda ...
... The SDSaway reagent is a valuable tool ... The presence of SDS in biological ... tightly bound SDS-protein complex, inhibits enzymatic activity ... presents as a contaminant in mass spectrometry ...
Biology Products: